| abstract |
The invention provides an antibody that binds to human alpha synuclein, contains three sections of CDR as defined by Kabat (SEQ ID NO: 25-27) in the light chain and three sections of CDR as defined by Kabat (SEQ ID NO: 10-12) in the heavy chain . The antibodies of the invention are useful, for example, for the treatment and / or diagnosis of diseases associated with alpha-synuclein, in particular with the accumulation of deposits of alpha-synuclein protein, in particular diseases of Levi bodies. |